Pinto L A, Shearer G M, Blazevic V
Experimental Immunology Branch, National Institutes of Health, Bethesda, Maryland, 20892, USA.
Clin Immunol. 2000 Oct;97(1):1-8. doi: 10.1006/clim.2000.4913.
Due to the limited efficacy of the current antiretroviral drug regimens in completely eradicating HIV and reconstituting the immune system, AIDS research is turning toward immune-based therapy to complement highly active antiretroviral therapy. Here we review potential mechanisms of protective cellular immunity and current HIV-specific immune-based strategies and discuss the rationale for novel hypothetical immunologic approaches for modulation of host antiviral immunity. One of the mechanisms by which the immune system exerts antiviral effects is via leukocyte generation of anti-HIV factors. Recent observations in this area of research suggest that non-HIV antigens can stimulate the in vitro production of anti-HIV activity by leukocytes from healthy uninfected individuals and HIV-infected patients. These findings may provide insights for the design of novel therapeutic or prophylactic approaches, which might contribute to modulating immune system control of HIV infection.
由于目前的抗逆转录病毒药物疗法在完全根除HIV和重建免疫系统方面疗效有限,艾滋病研究正转向基于免疫的疗法,以补充高效抗逆转录病毒疗法。在此,我们综述了保护性细胞免疫的潜在机制以及当前基于HIV特异性免疫的策略,并讨论了调节宿主抗病毒免疫的新型假设性免疫方法的基本原理。免疫系统发挥抗病毒作用的机制之一是通过白细胞产生抗HIV因子。该研究领域最近的观察结果表明,非HIV抗原可以刺激健康未感染个体和HIV感染患者的白细胞在体外产生抗HIV活性。这些发现可能为新型治疗或预防方法的设计提供思路,这可能有助于调节免疫系统对HIV感染的控制。